iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
₹2,648
(1.51%)
Nov 20, 2026|03:57:38 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,880₹0.15 -40%1,875-28.57%
--1,920₹0.35 0%4,5000%
--1,940₹0.15 0%2,6250%
--1,960₹0.05 -75%6,000-11.11%
--1,980₹0.6 0%5,2500%
3750%₹712 0%2,000₹0.05 -75%8,250-8.33%
--2,020₹0.15 0%1,5000%
2,2500%₹366.7 0%2,040₹0.25 0%2,2500%
--2,060₹0.25 0%3,0000%
12,3750%₹371.65 0%2,080₹0.25 0%3,0000%
--2,100₹0.15 -50%18,750-3.84%
7500%₹174.5 0%2,120₹0.15 -57.14%2,625-12.5%
3750%₹152.15 0%2,140₹0.2 0%6,750-28%
13,8750%₹175 0%2,160₹0.15 -50%5,6250%
9,0000%₹140 0%2,180₹0.4 0%3,0000%
48,375-10.41%₹428.5 -8.6%2,200₹0.05 -75%53,250-12.34%
8,6250%₹387.05 0%2,220₹0.35 0%7,8750%
19,5000%₹425 0%2,240₹0.05 -75%49,500-2.22%
10,8750%₹371.05 -7.23%2,260₹0.05 -80%21,000-6.66%
30,7500%₹330.25 -3.44%2,280₹0.05 -88.88%33,7501.12%
1,38,375-20.12%₹328 -0.3%2,300₹0.1 -71.42%1,09,500-6.70%
84,375-6.25%₹320.3 10.04%2,320₹0.1 -71.42%56,2501.35%
43,1250%₹291.5 27.32%2,340₹0.75 0%16,1250%
16,500-10.20%₹278.05 4.92%2,360₹0.3 -73.91%49,500-7.69%
14,625-2.5%₹262.65 6.48%2,380₹3.2 204.76%48,000-1.53%
82,500-17.91%₹227.2 -1.21%2,400₹0.5 -74.35%1,68,375-0.22%
14,6250%₹187 0%2,420₹0.3 -79.31%24,3753.17%
37,125-5.71%₹180 -11.22%2,440₹0.2 -88.23%34,125-2.15%
74,250-2.46%₹172.75 3.97%2,460₹0.95 -50%83,62513.77%
30,7500%₹161 19.34%2,480₹0.55 -74.41%11,250-30.23%
98,625-2.95%₹139.15 21.84%2,500₹0.35 -87.5%1,09,875-18.38%
45,000-1.63%₹111.65 14.63%2,520₹0.1 -96.29%45,750-46.49%
23,625-11.26%₹92.95 -12.55%2,540₹0.1 -97.91%25,500-70.81%
20,625-15.38%₹71.55 -28.59%2,560₹0.2 -97.16%48,000-33.33%
25,1254.68%₹59.45 28.12%2,580₹1.9 -81.37%17,625-37.33%
1,86,375-4.05%₹39.6 21.65%2,600₹2.55 -83.05%1,48,875-11.58%
39,7507.07%₹20 -11.89%2,620₹7.95 -67.35%46,875-10.07%
50,625-17.68%₹9.1 -47.85%2,640₹16.2 -54.87%43,12511.65%
2,45,625-2.96%₹9.7 -7.61%2,660₹31.35 -40.68%1,10,625-18.50%
69,375-36.86%₹2.55 -66.44%2,680₹50.3 -30.13%32,625-13%
3,03,375-10.21%₹3.35 -52.48%2,700₹76.45 -11.46%48,375-50%
39,375-13.22%₹2.45 -50%2,720--
1,53,000-22.87%₹1.85 -54.87%2,740--
76,125-6.01%₹1.55 -36.73%2,760₹141 0%10,1250%
19,87512.76%₹1.45 -27.5%2,780₹122.8 0%9,3750%
1,59,000-11.11%₹1.2 -35.13%2,800₹169.1 0%1,5000%
6,000-40.74%₹1.35 -46%2,820--
15,750-16%₹0.7 -39.13%2,840--
17,250-2.12%₹0.7 -22.22%2,860--
30,000-1.23%₹0.65 -23.52%2,880--
15,750-23.63%₹0.7 27.27%2,900₹237.3 0%8,6250%
3,0000%₹1.2 0%2,920₹275.5 0%3750%
15,0000%₹0.35 -22.22%2,940₹278.25 0%12,0000%
19,875-3.63%₹0.55 -38.88%2,960₹324 25.58%1,1250%
6,750-5.26%₹0.2 -60%3,040--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.